Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine

              Author:Sunzel, Eva-Maria   Rabinovich-Guilatt, Laura   Iyengar, Malini   Ruffo, Debra   Gutierrez, Maria   Gordon, Mark Forrest   Ghibellini, Giulia   

              Session Name:P2: Movement Disorders: Huntington's Disease and Chorea 2  

              Topic:Movement Disorders  

              Program Number:P2.015  

              Author Institution:Teva Pharmaceutical Industries Ltd , West Chester, PA  Teva Pharmaceutical Industries Ltd, Netanya, Israel  Teva Pharmaceutical Industries Ltd, Miramar, FL